HIMSS AsiaPac19 Conference Exhibition Will Address Issues in the Shifting Paradigm of Healthcare

Food and Healthcare Press Releases Friday August 30, 2019 11:11
BANGKOK--30 Aug--PRNewswire/InfoQuest

Healthcare and Information Management Systems Society Asia Pacific (HIMSS APAC), supported by the Ministry of Public Health Thailand, will organize the HIMSS AsiaPac19 Conference & Exhibition from 7-10 October 2019 in Bangkok, Thailand at the Centara Grand & Bangkok Convention Centre.

HIMSS AsiaPac19 is into its 13th installment as an annual regional conference that has been held in countries/regions including Australia, Mainland China, Hong Kong, Malaysia, Singapore, South Korea and Thailand. The theme of the event is Empowering Value Creation.

As the healthcare paradigm shifts due to factors such as the advancement of technology and the changing expectations of healthcare stakeholders, HIMSS AsiaPac19 will offer global best practice for over 1,200 expected attendees from over 30 countries to plan for, implement and commit to creating quantifiable and sustainable healthcare for patients and consumers. This will be achieved through tracks critically examined by esteemed global thought leaders and speakers throughout HIMSS AsiaPac19:

  • Sustainability & Growth
  • Patient Experience
  • Cyber Security
  • Unlocking the Value of Artificial Intelligence (AI)
  • Value-Based Care
  • Health 2.0

Other highlights of HIMSS AsiaPac19 include the 2nd regional HIMSS Asia Pacific CXO Dialogue, where C-Suite and industry leaders discuss policy, and current and future trends in healthcare; the Health 2.0 showcase with live demonstrations of healthcare innovations from budding entrepreneurs; and niche workshops and hospital tours for attendees to participate in.

Mr. Simon Lin, Vice President of HIMSS Asia Pacific, said: "Digitalization in healthcare is picking up pace in the region, public and private health systems alike. We are excited to be part of these digital transformation, and thrilled to be presenting some of these stories at this year's conference. In addition, locally in Thailand, its 4.0 initiative is propelling huge digital investments in the country, healthcare being a prominent vertical especially with Thailand's healthcare tourism being a vital economy driver. Returning to Bangkok this year, HIMSS will continue to collaborate with healthcare stakeholders in APAC to drive workforce development and private-public collaborations, with the ultimate aim of reforming health through information and technology."

Assistant Professor Korpong Rookkapan, MD, Chairperson of the HIMSS AsiaPac19 Organization Committee and Executive Consultant of Bumrungrad International, Thailand, said: "At this moment, we are at a critical point in deciding where healthcare digital transformation is heading to. As a member of the HIMSS AsiaPac19 Organizing Committee for the past 3 years, I know that there are many champions of healthcare in the Asia Pacific region who have achieved much and are ready to share inspiring stories, and we are bringing them to HIMSS AsiaPac19 to strengthen collaboration within the community and learn and grow together."

The call for demonstrations for the Health2.0 showcase is still open to provide solutions that aid chronic disease management. More information can be found at: https://www.himssasiapacconference.org/
About HIMSS

HIMSS is a global advisor and thought leader supporting the transformation of health through information and technology. As a mission driven non-profit, HIMSS offers unique expertise in health innovation, public policy, workforce development, research and analytics to advise global leaders, stakeholders and influencers on best practices in health information and technology. Through our innovation companies, HIMSS delivers key insights, education and engaging events to healthcare providers, governments and market suppliers, ensuring they have the right information at the point of decision.

As an association, HIMSS encompasses more than 72,000 individual members and 630 corporate members. We partner with hundreds of providers, academic institutions and health services organizations on strategic initiatives that leverage innovative information and technology. Together, we work to improve health, access and the quality and cost-effectiveness of healthcare.

Headquartered in Chicago, Illinois, HIMSS serves the global health information and technology communities with focused operations across North America, Europe, United Kingdom, the Middle East and Asia Pacific.

Latest Press Release

Menarini: Elcin Barker Ergun Group CEO

"Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas," commented Eric Cornut, Chairman of Menarini. Elcin Barker Ergun: "Menarini is a company admired on a global...

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase 3...

Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations

- Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications are present in 3-5% of non-small cell lung cancer patients and correlate with...

Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019

- Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study - Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal...

Newly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For #Complete Clearance# of Symptoms and Consider Combination Therapy For Severe Patients

Experts also welcome upsurge in the adoption of a rosacea signs and symptoms ('phenotype') led approach in clinical practice and announce the launch of prototype clinical tools to support physicians to optimize rosacea management Published online in the...

Related Topics